Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Appl Physiol 79: 1129-1133, 1995;
8750-7587/95 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamawaki, I.
Right arrow Articles by Konno, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamawaki, I.
Right arrow Articles by Konno, K.

Journal of Applied Physiology, Vol 79, Issue 4 1129-1133, Copyright © 1995 by American Physiological Society

ARTICLES

Effect of T-kinin on microvascular permeability and its modulation by peptidases in rat airways

I. Yamawaki, J. Tamaoki, Y. Takeda, A. Chiyotani, N. Sakai, S. Kameyama and K. Konno
First Department of Medicine, Tokyo Women's Medical College, Japan.

T-kinin (Ile-Ser-bradykinin), the product of T-kininogen, has been found in rat plasma during systemic inflammation, but the effect of this kinin on airway inflammatory response is unknown. We examined the effect of T-kinin on vascular permeability in airways of anesthetized rats in vivo by using photometric measurement of the extravasated Evans blue. Intravenous injection of T-kinin (0.1-10 mumol/kg) increased dye extravasation in a dose-dependent manner, with 134% for trachea and 117% for bronchi by 1 mumol/kg. Pretreatment with bradykinin B2-receptor antagonist Hoe-140 (100 nmol/kg), but not the B1-receptor antagonist des-Arg9-Leu8-bradykinin (5 mg/kg), abolished plasma extravasation evoked by T-kinin (1 mumol/kg). NK1 tachykinin-receptor antagonist CP-99994 (4 mg/kg) did not affect T-kinin-induced vascular leakage. Pretreatment with captopril (2.5 mg/kg), angiotensin-converting enzyme inhibitor, potentiated T-kinin (100 nmol/kg)-induced plasma extravasation, whereas phosphoramidon (2.5 mg/kg), a neutral endopeptidase inhibitor, had no effect. We conclude that T-kinin produces airway vascular extravasation via stimulation of B2 receptors. The effect is modulated by endogenous angiotensin-converting enzyme and is not mediated via activation of sensory nerve.


This article has been cited by other articles:


Home page
 IOVSHome page
Q. Xu, T. Qaum, and A. P. Adamis
Sensitive Blood-Retinal Barrier Breakdown Quantitation Using Evans Blue
Invest. Ophthalmol. Vis. Sci., March 1, 2001; 42(3): 789 - 794.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
C. Murone, S. Y. Chai, W. Müller-Esterl, F. A. O. Mendelsohn, and J. Clements
Localization of Bradykinin B2 Receptors in the Endometrium and Myometrium of Rat Uterus and the Effects of Estrogen and Progesterone
Endocrinology, July 1, 1999; 140(7): 3372 - 3382.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. Tamaoki, I. Yamawaki, E. Tagaya, M. Kondo, K. Aoshiba, J. Nakata, and A. Nagai
Effect of azelastine on platelet-activating factor-induced microvascular leakage in rat airways
Am J Physiol Lung Cell Mol Physiol, February 1, 1999; 276(2): L351 - L357.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online